Results 71 to 80 of about 14,372 (207)
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.Abstract Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient. Case Presentation A 49‐year‐old Japanese woman with treatment‐resistant residual schizophrenia exhibited persistent
Yoshiki Kasagi +2 more
wiley +1 more source
Acupuncture treatment for hyperprolactinemia [PDF]
, 2018 • Hyperprolactinemia is a disorder of the endocrine system that causes the body to produce higher levels of prolactin than normal. • Symptoms of hyperprolactinemia in women are: irregular menstrual cycle, production of breast milk in absence of ...
Ahtarova, Ivana +3 more
core
The FASEB Journal, Volume 40, Issue 9, 15 May 2026.Interplay between VEGF‐A‐driven angiogenesis and DRD2‐mediated inhibition. Tumor‐derived VEGF‐A activates VEGFR2 on endothelial cells, triggering proangiogenic signaling pathways that promote abnormal vessel growth and vascular leakage. VEGF‐A also induces DRD2 expression, establishing a feedback mechanism.
Venu Akkanapally +6 more
wiley +1 more source
Hiperprolactinemia em pacientes femininas: estudo de seis casos. [PDF]
, 1999 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Tocoginecologia, Curso de Medicina, Florianópolis ...
Martins, Angelo Francisco
core
Case Reports: Aripripazole Reduces Risperidone-Induced Hyperprolactinemia [PDF]
, 2020 Many schizophrenic patients treated with typical or atypical antipsychotics (AP) such as risperidone show significant clinical alterations as changes in sexual activity, menstrual cycle, amenorrhea, galattorrea and cardiovascular disorders because of AP ...
Andrea Ingenito +4 more
core +1 more source
Advanced Science, Volume 13, Issue 27, 13 May 2026.Impaired endometrial receptivity contributes to the poor pregnancy outcomes in women with PCOS. The authors found that decreased endometrial IL‐22 levels and disrupted STAT3‐IGFBP5 signaling pathway contributed to impaired endometrial receptivity. Supplementation with IL‐22 or IGFBP5 exerts a protective effect on implantation failure in PCOS‐like mice,
Baoying Liao +13 more
wiley +1 more source
Anais da Faculdade de Medicina de Olinda, 2018 Objective: To evaluate the importance of screening for macroprolactin in symptomatic patients with apparent idiopathic hyperprolactinemia. Methods: During 20 months, the prevalence of macroprolactinemia was evaluated among consecutive symptomatic female
Lucio Vilar +11 more
doaj +1 more source
Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center
The Pan African Medical Journal, 2020 Macroprolactinemia frequently causes misdiagnosis, unnecessary investigation and inappropriate treatment in hyperprolactinemic patients. Aim of this study is to investigate the prevalence and clinical characteristics of Thai patients with ...
Phronpan Chutpiboonwat +5 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background and Aims Obsessive–compulsive disorder (OCD) is a chronic condition associated with marked functional impairment and high rates of treatment resistance. Converging evidence implicates glutamatergic dysregulation in OCD pathophysiology.
Ahmad Zolghadriha +2 more
wiley +1 more source
Hyperprolactinemia With Aripiprazole
, 2014 Aripiprazole, due to its partial agonist activity at the D2 receptors, is often recommended as the drug of choice in patients who develop antipsychotic-induced hyperprolactinemia.
Behere, Rishikesh V. +5 more
core +1 more source